Literature DB >> 33509796

Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha et al.

Christian Dejaco1,2, Johannes Wj Bijlsma3, Frank Buttgereit4.   

Abstract

Entities:  

Keywords:  COVID-19; autoimmune diseases; epidemiology; health services research; vaccination

Year:  2021        PMID： 33509796     DOI： 10.1136/annrheumdis-2021-219866

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines.

Authors:  Nelly Ziade; Ihsane Hmamouchi; Lina El Kibbi; Melissa Daou; Nizar Abdulateef; Fatemah Abutiban; Bassel Elzorkany; Chafia Dahou-Makhloufi; Wafa Hamdi; Samar Al Emadi; Hussein Halabi; Khalid A Alnaqbi; Sima Abu Al Saoud; Soad Hashad; Radouane Niamane; Manal El Rakawi; Layla Kazkaz; Sahar Saad; Mervat Eissa; Ilanca Fraser; Basel Masri
Journal:  Rheumatol Int       Date:  2022-01-06       Impact factor: 3.580

2.  Lessons from experiences of accessing healthcare during the pandemic for remobilizing rheumatology services: a national mixed methods study.

Authors:  LaKrista Morton; Kevin Stelfox; Marcus Beasley; Gareth T Jones; Gary J Macfarlane; Peter Murchie; John Paton; Rosemary Hollick
Journal:  Rheumatol Adv Pract       Date:  2022-02-16

3.  Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1).

Authors:  Diego Benavent; Marco Garrido-Cumbrera; Chamaida Plasencia-Rodríguez; Helena Marzo-Ortega; Laura Christen; José Correa-Fernández; Pedro Plazuelo-Ramos; Dale Webb; Victoria Navarro-Compán
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-01-19       Impact factor: 5.346
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.